financetom
Business
financetom
/
Business
/
Airbus says it has 60 jets awaiting engines, now including from Pratt & Whitney
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Airbus says it has 60 jets awaiting engines, now including from Pratt & Whitney
Jul 30, 2025 11:00 AM

PARIS (Reuters) -Airbus CEO Guillaume Faury said the number of completed airframes still waiting for delayed engine deliveries had risen to 60 and that the delays now involved Pratt & Whitney on top of earlier problems with rival CFM.

Speaking in a half-yearly media briefing, however, Faury defended the company's target of raising deliveries by 7% to 820 jets for 2025 as a whole, which he said was supported by an agreement with the engine makers to secure enough deliveries.

He also said Airbus was progressing towards the planned opening of a second assembly line in China at end-2025 and, on defence, pledged to stay onboard a Franco-German-Spanish fighter project despite tensions with partner Dassault Aviation.

(Reporting by Tim Hepher, Editing by Benoit Van Overstraeten and Ros Russell)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cargo Therapeutics to Cut Workforce by 50%, Discontinue Lymphoma Treatment Study -- Shares Down Pre-Bell
Cargo Therapeutics to Cut Workforce by 50%, Discontinue Lymphoma Treatment Study -- Shares Down Pre-Bell
Jan 30, 2025
06:14 AM EST, 01/30/2025 (MT Newswires) -- Cargo Therapeutics ( CRGX ) said Wednesday that it will discontinue the phase 2 study of firicabtagene autoleucel, or firi-cel, for patients with large B-cell lymphoma, and reduce its workforce by about 50% to preserve cash for the development of other product candidates. The company said results from an ad-hoc analysis of the...
Thermo Fisher Scientific's Q4 Adjusted Earnings, Revenue Rise
Thermo Fisher Scientific's Q4 Adjusted Earnings, Revenue Rise
Jan 30, 2025
06:09 AM EST, 01/30/2025 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) reported Q4 adjusted earnings Thursday of $6.10 per diluted share, up from $5.67 a year earlier. Analysts polled by FactSet expected $5.94. Revenue for the quarter ended Dec. 31 was $11.40 billion, compared with $10.89 billion a year earlier. Analysts surveyed by FactSet expected $11.28 billion. ...
Dow's Q4 Earnings, Net Sales Decline
Dow's Q4 Earnings, Net Sales Decline
Jan 30, 2025
06:14 AM EST, 01/30/2025 (MT Newswires) -- Dow (DOW) said Thursday it broke even in Q4, compared with operating earnings of $0.43 per share a year earlier. Analysts polled by FactSet expected $0.22. Net sales for the quarter ended Dec. 31 was $10.41 billion, down from $10.62 billion a year earlier. Analysts surveyed by FactSet expected $10.51 billion. ...
Dow misses fourth quarter profit estimates, to lay off 1,500 employees
Dow misses fourth quarter profit estimates, to lay off 1,500 employees
Jan 30, 2025
Jan 30 (Reuters) - Chemical firm Dow missed fourth-quarter profit estimates on Thursday, and said it will lay off 1,500 employees globally. The chemical industry has been struggling with weak demand recovery, especially in Europe, where a challenging regulatory environment has led some companies to rethink their strategies. Last year, Dow announced it had begun reviewing some of its European...
Copyright 2023-2026 - www.financetom.com All Rights Reserved